M

Maravai LifeSciences Holdings
D

MRVI

5.05000
USD
-0.25
(-4.72%)
Market Open
Volume
32,456
EPS
-0
Div Yield
-
P/E
-3
Market Cap
713,472,830
OverviewSignalsIdeasNews
Related Instruments
    AMAT
    AMAT
    -17.080
    (-9.18%)
    171.280 USD
    A
    AMKR
    -0.820
    (-3.15%)
    25.210 USD
    ASML
    ASML
    -34.84
    (-5.03%)
    669.96 USD
    AVGO
    AVGO
    -5.640
    (-3.31%)
    163.750 USD
    INTC
    INTC
    -0.695
    (-2.78%)
    24.145 USD
    KLAC
    KLAC
    -30.33
    (-4.70%)
    614.59 USD
    LRCX
    LRCX
    -4.760
    (-6.36%)
    72.330 USD
    MCHP
    MCHP
    -2.740
    (-4.18%)
    62.870 USD
    NXPI
    NXPI
    -6.840
    (-3.05%)
    217.140 USD
    QCOM
    QCOM
    -3.460
    (-2.11%)
    157.585 USD
    S
    SWKS
    -0.310
    (-0.37%)
    83.710 USD
    More
News

Title: Maravai LifeSciences Holdings

Sector: Healthcare
Industry: Biotechnology
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.